In Utero Gene Therapy Consensus Statement from the IFeTIS

Mol Ther. 2019 Apr 10;27(4):705-707. doi: 10.1016/j.ymthe.2019.02.015. Epub 2019 Mar 2.

¹ Wake Forest Institute for Regenerative Medicine, Fetal Research and Therapy Program, Winston Salem, NC 27157, USA. Electronic address: galmeida@wakehealth.edu.
² Gene Transfer Technology Group, Institute for Women's Health, University College London, 86-96 Chenies Mews, London WC1E 6HX, UK; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
³ Department of Obstetrics and Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, Singapore; Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
⁴ Division of Pediatric General, Thoracic and Fetal Surgery, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
⁵ Department of Surgery, Center for Maternal-Fetal Precision Medicine, University of California San Francisco, San Francisco, CA, USA.
⁶ Wake Forest Institute for Regenerative Medicine, Fetal Research and Therapy Program, Winston Salem, NC 27157, USA.

No abstract available

Publication types